Site Map

Site Map of http://www.researchandmarkets.com

• Site Map

• Antibiotics Market in Malaysia to 2016
• Antibiotics Market in Mexico to 2016
• Antibiotics Market in Moldova to 2016
• Antibiotics Market in Mongolia to 2016
• Antibiotics Market in Morocco to 2016
• Antibiotics Market in Nepal to 2016
• Antibiotics Market in Netherlands to 2016
• Antibiotics Market in Nigeria to 2016
• Antibiotics Market in Norway to 2016
• Antibiotics Market in Oman to 2016
• Antibiotics Market in Pakistan to 2016
• Antibiotics Market in Panama to 2016
• Antibiotics Market in Peru to 2016
• Antibiotics Market in Philippines to 2016
• Antibiotics Market in Poland to 2016
• Antibiotics Market in Portugal to 2016
• Antibiotics Market in Romania to 2016
• Antibiotics Market in Russia to 2016
• Antibiotics Market in Senegal to 2016
• Antibiotics Market in Singapore to 2016
• Antibiotics Market in Slovakia to 2016
• Antibiotics Market in Slovenia to 2016
• Antibiotics Market in South Africa to 2016
• Antibiotics Market in South Korea to 2016
• Antibiotics Market in Spain to 2016
• Antibiotics Market in Sri Lanka to 2016
• Antibiotics Market in Sudan to 2016
• Antibiotics Market in Sweden to 2016
• Antibiotics Market in Thailand to 2016
• Antibiotics Market in Turkey to 2016
• Antibiotics Market in Ukraine to 2016
• Antibiotics Market in United Kingdom to 2016
• Antibiotics Market in United States to 2016
• Antibiotics Market in Uruguay to 2016
• Antibiotics Market in Vietnam to 2016
• Antibiotics Markets - African Package
• Antibiotics Markets - American Package
• Antibiotics Markets - Asian Package
• Antibiotics Markets - Eastern European Package
• Antibiotics Markets - European Package
• Antibiotics Markets - Global Package
• Antibiotics Markets - Top 10 Global Countries Package
• Antibiotics Markets - Top 5 American Countries Package
• Antibiotics Markets - Top 5 Asian Countries Package
• Antibiotics Markets - Top 5 European Countries Package
• Antibiotics Markets - Western European Package
• Antibiotics Partnering Terms and Agreements
• Antibody drug conjugates for cancer treatment: Clinical Trial Pipeline
• Antibody Drug Target Atlas in Oncology
• Antibody Partnering Terms and Agreements
• Antibody Pipeline Database: 1-Year Subscription
• Antibody Sourcing and Usage Survey
• Antibody Technologies and Attrition Rates – an industry analysis 2013
• Antibody Technology Companies 2010
• Antibody Technology Developments (Technical Insights)
• Anticancer Drug Toxicity. Prevention, Management, and Clinical Pharmacokinetics
• Anticholinergic Agents in the Upper and Lower Airways. Lung Biology in Health and Disease
• Anticholinesterase Pesticides. Metabolism, Neurotoxicity, and Epidemiology
• Anticoagulants - Global Strategic Business Report
• Anticoagulants in Stroke Prevention in Atrial Fibrillation (SPAF): Novel Oral Anticoagulants with Superior Safety Profile will Drive the Market
• Anticonvulsants Market Forecast
• Anticonvulsants Market to 2016 - Cost Advantage and Dosage Convenience Provided by Generic Anticonvulsants Will Limit Commercial Opportunities for Novel Therapies
• Antidepressants - Global Strategic Business Report
• Antidepressants Market Forecast
• Antidepressants Market to 2018 - Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs) Continue to Dominate in the Absence of Effective Therapeutic Alternatives
• Antidiabetics in Australia Market Forecast
• Antidiabetics Market Forecast
• Antidyslipidemics - Genericization and Negative Trial Data Drive Market Shrinkage
• Antiepileptic Drugs to Treat Psychiatric Disorders. Medical Psychiatry Series
• Antifungals Market to 2016 - Promising Antifungals in Pipeline Includes Novel Azoles, Polyenes and Echinocandin
• Antifungals Market to 2017 - Generic Erosion of Major Polyenes, Azoles, Allylamines and Echinocandins to Slow Value Growth
• Antigen-Presenting Cells and the Eye
• Antihypertensives Market to 2016 - Generic Erosion Following Patent Expiry of Major ARBs to Impact the Market
• Antimicrobial Pharmacodynamics in Theory and Clinical Practice. Edition No. 2. Infectious Disease and Therapy
• Antithrombotics Market Forecast
• Antiviral Drug Development
• Antivirals - Global Strategic Business Report
• Antivirals Market to 2016 - Antiretroviral Agents and Combination Therapies to be Major Drivers HIV and Hepatitis C Markets
• Antivirals: Novel Targets, Technologies, and Dealmaking
• Anxiety Disorders - Global Strategic Business Report
• Anxiety Disorders Therapeutics - Pipeline Assessment and Market Forecasts to 2017
• Anxiety Partnering 2007-2013
• Anxiety Therapy Area Pipeline Report
• Anyara (Renal Cell Carcinoma) - Analysis and Forecasts to 2022
• Aoxing Pharmaceutical Company, Inc. (Formerly China Aoxing Pharmaceutical Company, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• AP Pharma's APF530: Can it deliver the goods?
• Aperio Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Aphios Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• API Sourcing in China
• Apidra (Type 2 Diabetes) - Analysis and Forecasts to 2020
• Apixaban - Comprehensive patent search
• Apixaban - Key patent, SPC, and data exclusivity expiry (44 country coverage)
• Apixaban - Key patent, SPC, and data exclusivity expiry (7 country coverage)
• Aplastic Anemia - Pipeline Review, H1 2012
• Aplastic Anemia - Pipeline Review, H2 2012
• Aplastic Anemia Global Clinical Trials Review, H2, 2012
• Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
• Apnea Global Clinical Trials Review, Q4, 2010
• ApoImmune, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Apollo Medical Holdings, Inc.,(AMEH) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Apoptosis 2009: Opportunities in Cancer and Other Diseases
• Aposense, Ltd. (formerly NST NeuroSurvival Technologies, Ltd.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Apotex, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT and Financial Report
• Appendicitis Global Clinical Trials Review, H1, 2012
• Appendicitis Global Clinical Trials Review, H1, 2013
• Appendicitis Global Clinical Trials Review, Q1, 2011
• Appetite Global Clinical Trials Review, Q1, 2011
• Applications of Stem Cells in Drug Discovery
• Applied Biosystems/MDS Sciex Instruments - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Applied Logistic Regression. 3rd Edition. Wiley Series in Probability and Statistics
• Applied Statistics. Analysis of Variance and Regression. 3rd Edition. Wiley Series in Probability and Statistics
• Applied Statistics. Analysis of Variance and Regression. 3rd Edition. Wiley Series in Probability and Statistics
• Applikon Biotechnology B.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Approaches to High Throughput Toxicity Screening
• Approval of Kalydeco Brings New Hope for CF Patients with G551D Mutation
• APR Applied Pharma Research S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Apredica, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Apria Healthcare Group Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT and Financial Report
• Apria Healthcare Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• APT Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Aptalis (formerly Axcan Pharma Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Apthera, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Aptuit, Inc. (Formerly Eagle-Picher Technologies, LLC) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Aquaculture- Global Technology Developments
• Aquapharm Bio-Discovery, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms. Edition No. 3. Drugs and the Pharmaceutical Sciences Part No. 176
• Aradigm Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Aradigm Corporation,(ARDM) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Arana Therapeutics Limited (formerly Peptech Limited) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Arbor Pharmaceuticals - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• ARCA biopharma, Inc. (formerly Nuvelo, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Arcadia Resources Inc.,(KADR) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Arch Pharmalabs, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Archimedes Development, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Archimedes Pharma Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• ArcticDx, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Arcxis Biotechnologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Ardea’s RDEA594 - Another novel agent for gout
• Ardent Health Services LLC: Pharmaceuticals and Healthcare Company Profile, SWOT and Financial Report
• Are There Changes Ahead for the Generalized Anxiety Disorder Market?
• Arena's Lorcaserin: Safety issues improving, but efficacy lagging as newer obesity drugs emerge
• Argenta Discovery, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Argentina - Pharmaceutical Industry Overview
• Argentina Pharmaceuticals and Healthcare Report Q1 2008
• Argentina Pharmaceuticals and Healthcare Report Q1 2009
• Argentina Pharmaceuticals and Healthcare Report Q1 2010
• Argentina Pharmaceuticals and Healthcare Report Q1 2011
• Argentina Pharmaceuticals and Healthcare Report Q2 2008
• Argentina Pharmaceuticals and Healthcare Report Q2 2009
• Argentina Pharmaceuticals and Healthcare Report Q2 2010
• Argentina Pharmaceuticals and Healthcare Report Q2 2011
• Argentina Pharmaceuticals and Healthcare Report Q2 2012
• Argentina Pharmaceuticals and Healthcare Report Q2 2013
• Argentina Pharmaceuticals and Healthcare Report Q3 2007
• Argentina Pharmaceuticals and Healthcare Report Q3 2008
• Argentina Pharmaceuticals and Healthcare Report Q3 2010
• Argentina Pharmaceuticals and Healthcare Report Q3 2012
• Argentina Pharmaceuticals and Healthcare Report Q4 2009
• Argentina Pharmaceuticals and Healthcare Report Q4 2010
• Argentina Pharmaceuticals and Healthcare Report Q4 2011
• Argentina Pharmaceuticals and Healthcare Report Q4 2012
• Arginetix, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Ariad and Merck's Ridaforolimus: is this mTOR inhibitor any different or any better?
• Aricept (Alzheimer's disease) - Analysis and Forecasts to 2022
• Ark Therapeutics Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Arno Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• ArQule Inc,(ARQL) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• ArQule, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Arrayit Corporation (formerly Integrated Media Holdings, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Arrhythmia Partnering 2007-2013
• Arrhythmia Research Technology,(HRT) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Arriani Pharmaceuticals S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Arrythmia - Pipeline Review, Q4 2010
• Arseus NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Arteriocyte, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Arteriosclerosis Global Clinical Trials Review, Q4, 2010
• Arthritis - Pipeline Review, H1 2012
• Arthritis - Pipeline Review, H1 2013
• Arthritis - Pipeline Review, H2 2012
• Arthritis Global Clinical Trials Review, H1, 2012
• Arthritis Global Clinical Trials Review, Q2, 2011
• Arthritis Partnering 2007-2013
• Arthritis Therapeutics Market to 2016 - Biologics Revolutionize Treatment of Rheumatoid Arthritis and Psoriatic Arthritis
• Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications
• Arthritis Therapy Area Pipeline Report
• ArthroCare Corp,(ARTC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• ArthroCare Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Arthur G. James Cancer Hospital & Richard J. Solove Research Institute - Developmental Therapeutics Review - Q1 2011
• Aruna Biomedical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• ARUP Laboratories - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• ARYx Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Asahi Kasei Pharma America Corp. (formerly Artisan Pharma, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Asan Medical Center - Developmental Therapeutics Review - Q1 2011
• Ascalon International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Ascites - Pipeline Review, H1 2012
• Ascites - Pipeline Review, H2 2011
• Ascites - Pipeline Review, Q1 2011
• Ascites - Pipeline Review, Q4 2010
• Ascites Global Clinical Trials Review, H1, 2012
• Ascites Global Clinical Trials Review, Q1, 2011
• ASCOT (The Anglo-Scandinavian Cardiac Outcomes Trial) - BPLA (Blood Pressure Lowering Arm) - An Overview
• Asia Medical Tourism Analysis (2008 – 2013)
• Asia Pacific Cognitive Health Ingredients in Human Nutrition
• Asia Pacific Market for Bone Graft Substitutes and Other Biomaterials 2009
• Asia Pacific Pharma Sector Analysis
• Asia Pacific Pharmaceutical Market: Strategic Assessments of Leading Suppliers
• Asia-Pacific Pharmaceutical Market Analysis, 2010-2014
• Asia-Pacific Pharmaceuticals Sectors : A Company and Industry Analysis (April 2008)
• Asia: Threat or Opportunity?
• Asian American Communities and Health. Context, Research, Policy, and Action. Public Health/Vulnerable Populations
• Asian Pharmaceutical Directory 2013
• Asian Pharmaceuticals and Healthcare Reports
• ASKA Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• ASP1941 (Type 2 Diabetes) - Analysis and Forecasts to 2020
• Aspen Technology, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• AspenBio Pharma, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Asperger's Disorder. Medical Psychiatry Series
• Aspergillosis - Pipeline Review, H2 2012
• Aspergillosis - Pipeline Review, Q4 2010
• Aspergillosis Global Clinical Trials Review, Q4, 2010
• Aspirin Production & Market in China
• Assay Designs, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd Edition
• Assisted Living Concepts Inc.,(ALC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Assurant Inc,(AIZ) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Astellas Pharma Europe, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Astellas Pharma Inc,(ALPMY) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Astellas Pharma Inc. - SWOT Analysis
• Astellas Pharma Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT and Financial Report
• Astex Therapeutics Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Asthma
• Asthma (Event Driven)
• Asthma - Pipeline Review, Q4 2010
• Asthma and COPD Drug Market - Global Industry Analysis, Market Size, Share, Trends, Growth and Forecasts, 2010 - 2017
• Asthma and Respiratory Infections. Lung Biology in Health and Disease
• Asthma as an Inflammatory Disease
• Asthma Global Clinical Trials Review, Q4, 2010
• Asthma in the Elderly. Lung Biology in Health and Disease
• Asthma in the Workplace. Edition No. 3
• Asthma Market Forecast
• Asthma Partnering 2007-2013
• Asthma Prevention. Lung Biology in Health and Disease
• Asthma Therapeutics - Pipeline Assessment and Market Forecasts to 2018
• Asthma Therapy Area Pipeline Report
• Asthma's Impact on Society. The Social and Economic Burden. Lung Biology in Health and Disease
• Asthma. Its Pathogenesis and Treatment. Lung Biology in Health and Disease Part No. 49
• Asthma/COPD Market Forecast
• Astra Tech AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• AstraZeneca plc,(AZN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• AstraZeneca PLC: Pharmaceuticals and Healthcare Company Profile, SWOT and Financial Report
• AstraZeneca's Brilinta - Survival data shines, except in North America... Should it matter?
• AstraZeneca: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
• Astrocytoma - Pipeline Review, H2 2012
• Astrocytoma - Pipeline Review, Q4 2010
• Astrocytoma Global Clinical Trials Review, Q4, 2010
• At Risk in America. The Health and Health Care Needs of Vulnerable Populations in the United States. 2nd Edition. Public Health/Vulnerable Populations
• AtCor Medical Holdings Limited,(AMDHF) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Athenahealth Inc,(ATHN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Athera Biotechnologies AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Atherosclerosis - Pipeline Review, H2 2012
• Atherosclerosis Partnering 2007-2013
• Atherosclerosis Therapy Area Pipeline Report
• Atlantic Biologicals Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Atlantic Biologicals Diagnostics L.L.C. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Atlas and Manual of Cardiovascular Multidetector Computed Tomography
• Atlas of Alzheimer's Disease
• Atlas of Bipolar Disorders
• Atlas of Common Subluxations of the Human Spine and Pelvis
• Atlas of Fetal MRI
• Atlas of Fundus Fluorescein Angiography
• Atlas of Glaucoma. Edition No. 2
• Atlas of Imaging of the Paranasal Sinuses. Edition No. 2
• Atlas of Neuro-ophthalmology
• Atlas of Oculoplastic and Orbital Surgery
• Atlas of Optical Coherence Tomography of Macular Diseases
• Atlas of Psychiatric Pharmacotherapy. Edition No. 2
• Atlas of Skull Base Surgery
• Atlas of Sleep Medicine
• Aton Pharma, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Atopic Dermatitis (Eczema) - Pipeline Review, H1 2012
• Atopic Dermatitis (Eczema) - Pipeline Review, H2 2011
• Atopic Dermatitis (Eczema) - Pipeline Review, H2 2012
• Atopic Dermatitis (Eczema) Global Clinical Trials Review, H1, 2012
• Atopic Dermatitis (Eczema) Global Clinical Trials Review, Q2, 2011
• Atopic Dermatitis - Pipeline Review, H1 2013
• Atopic Dermatitis - Pipeline Review, Q1 2011
• Atopic Dermatitis - Pipeline Review, Q4 2010
• Atopic Dermatitis Global Clinical Trials Review, H1, 2013
• Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
• Atopic Dermatitis: Generic Erosion Leads to Stagnant Market
• Atrial Fibrillation (Event Driven)
• Atrial Fibrillation - Pipeline Review, H2 2012
• Atrial Fibrillation - Pipeline Review, Q4 2010
• Atrial Fibrillation Therapeutics - Pipeline Assessment and Market Forecasts to 2017
• Atrial Fibrillation Therapy Area Pipeline Report
• Atrial Fibrillation: Emerging Drug Discovery Targets and Therapeutic Candidates
• AtriCure, Inc.,(ATRC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Atrion Corporation,(ATRI) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Attention Deficit Disorder with Hyperactivity Therapy Area Pipeline Report
• Attention Deficit Disorder. Practical Coping Mechanisms. Edition No. 2
• Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2012
• Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, Q4 2010
• Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, Q4, 2010
• Attention Deficit Hyperactivity Disorder Partnering 2007-2013
• Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment
• Atypical Antipsychotics: Life-Cycle Management and Future Trends
• aTyr Pharma, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Aureon Biosciences, Inc. (formerly Aureon Biosciences Corporation; Aureon Laboratories, Inc.; Aurigen Bioscience, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Aushon BioSystems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Australia Drug Patent Inventor Report - 2012
• Australia Generics Market
• Australia Pharmaceutical Market Analysis, 2010-2014
• Australia Pharmaceutical Market Overview - Reforms and continued price cuts will change the healthcare landscape
• Australia Pharmaceuticals & Healthcare Report Q1 2008
• Australia Pharmaceuticals and Healthcare Report Q1 2009
• Australia Pharmaceuticals and Healthcare Report Q1 2010
• Australia Pharmaceuticals and Healthcare Report Q1 2011
• Australia Pharmaceuticals and Healthcare Report Q1 2012
• Australia Pharmaceuticals and Healthcare Report Q2 2008
• Australia Pharmaceuticals and Healthcare Report Q2 2009
• Australia Pharmaceuticals and Healthcare Report Q2 2010
• Australia Pharmaceuticals and Healthcare Report Q2 2011
• Australia Pharmaceuticals and Healthcare Report Q2 2012
• Australia Pharmaceuticals and Healthcare Report Q3 2008
• Australia Pharmaceuticals and Healthcare Report Q3 2010
• Australia Pharmaceuticals and Healthcare Report Q3 2011
• Australia Pharmaceuticals and Healthcare Report Q3 2012
• Australia Pharmaceuticals and Healthcare Report Q3 2013
• Australia Pharmaceuticals and Healthcare Report Q4 2008
• Australia Pharmaceuticals and Healthcare Report Q4 2009
• Australia Pharmaceuticals and Healthcare Report Q4 2010
• Australia Pharmaceuticals and Healthcare Report Q4 2012
• Australian Drug Sector: Industry Profile
• Australian Drug Sector: Sector Report
• Australian Pharmaceutical Sector: Industry Profile
• Australian Pharmaceutical Sector: Sector Report
• Australian Pharmaceuticals and Life Sciences IT Market
• Authentication News
• Autism - Drug Pipeline Analysis and Market Forecasts to 2016
• Autism - Pipeline Review, H2 2012
• Autism - Pipeline Review, Q4 2010
• Autism – Pipeline Review, H1 2013
• Autism Spectrum Disorders - High Unmet Needs Create Significant Market Opportunities
• Autistic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018
• AutoGenomics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Autoimmune and Inflammation Pipeline Databook
• Autoimmune Disease Series: Strategies for Success in the Challenging Sjögren's Syndrome Market
• Autoimmune Disease Series: Systemic Sclerosis--Novel Treatment Approaches on the Horizon
• Autoimmune Diseases Therapy Area Pipeline Report
• Autoimmune Disorders - Pipeline Review, H2 2012
• Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012-2017) (Neurodegenerative, cardiovascular, cancer & autoimmune, skin and infectious diseases)
• Automated Dispensing Machine Market in Japan 2010-2014
• Automation and Control Solutions in the European Pharmaceutical Market
• Automation and Validation of Information in Pharmaceutical Processing. Drugs and the Pharmaceutical Sciences
• Auxilium Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Auxilium Pharmaceuticals, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT and Financial Report
• Avandia (Type 2 Diabetes) - Analysis and Forecasts to 2020
• AVANIR Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Avantis Medical Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Avastin (Renal Cell Carcinoma) - Analysis and Forecasts to 2022
• AVEO Pharmaceuticals’ and Astellas Pharma’s Tivozanib - Can this angiogenesis inhibitor distinguish itself from the field?
• Avesthagen Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Avexa Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Avian Influenza
• Avid Bioservices, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Avid Radiopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Avila Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Avitaminosis (Hypovitaminosis) - Pipeline Review, H2 2012
• Avitar, Inc.,(AVTI) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Axitinib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
• Axitinib - Key patent, SPC, and data exclusivity expiry (7 country coverage)
• AxoGen Inc,(AXGN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• AxoGen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Axonal Regeneration in the Central Nervous System. Neurological Disease and Therapy
• Axxam SpA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Azaya Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• B-cell Lymphomas Global Clinical Trials Review, Q4, 2010
• BAC B.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bachem AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Back Pain - Pipeline Review, Q4 2010
• Back Pain Report 2008
• Bacterial Conjunctivitis - Pipeline Review, H1 2012
• Bacterial Conjunctivitis - Pipeline Review, H2 2011
• Bacterial Conjunctivitis - Pipeline Review, H2 2012
• Bacterial Conjunctivitis - Pipeline Review, Q2 2011
• Bacterial Infections Therapy Area Pipeline Report
• Bacterial Partnering Terms and Agreements
• Bacteriuria Global Clinical Trials Review, H2, 2011
• Bacteriuria Global Clinical Trials Review, H2, 2012
• Bahrain Pharmaceuticals and Healthcare Report Q1 2009
• Bahrain Pharmaceuticals and Healthcare Report Q1 2010
• Bahrain Pharmaceuticals and Healthcare Report Q1 2011
• Bahrain Pharmaceuticals and Healthcare Report Q1 2012
• Bahrain Pharmaceuticals and Healthcare Report Q1 2013
• Bahrain Pharmaceuticals and Healthcare Report Q2 2010
• Bahrain Pharmaceuticals and Healthcare Report Q2 2013
• Bahrain Pharmaceuticals and Healthcare Report Q3 2008
• Bahrain Pharmaceuticals and Healthcare Report Q3 2009
• Bahrain Pharmaceuticals and Healthcare Report Q3 2011
• Bahrain Pharmaceuticals and Healthcare Report Q3 2012
• Bahrain Pharmaceuticals and Healthcare Report Q4 2009
• Bahrain Pharmaceuticals and Healthcare Report Q4 2010
• Bahrain Pharmaceuticals and Healthcare Report Q4 2012
• Balaglitazone (DRF 2593, NN2344) - R & D Biopharmaceutical & Pharmaceutical Product Profile
• Ballistics 2011: 26th International Symposium on Ballistics
• Bangladesh Pharmaceuticals and Healthcare Report Q1 2010
• Bangladesh Pharmaceuticals and Healthcare Report Q1 2012
• Bangladesh Pharmaceuticals and Healthcare Report Q2 2010
• Bangladesh Pharmaceuticals and Healthcare Report Q2 2013
• Bangladesh Pharmaceuticals and Healthcare Report Q3 2012
• Bangladesh Pharmaceuticals and Healthcare Report Q4 2010
• Bangladesh Pharmaceuticals and Healthcare Report Q4 2011
• Bangladesh Pharmaceuticals and Healthcare Report Q4 2012
• Bangladesh Pharmaceutiicals and Healthcare Report Q3 2011
• Banyan Corporation,(BNYN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Banzel / Inovelon (Epilepsy) - Forecast and Market Analysis to 2022
• Barrett's Esophagus Global Clinical Trials Review, H2 2011
• Barrett's Esophagus Global Clinical Trials Review, Q1, 2011
• Barretts Esophagus Global Clinical Trials Review, H2, 2012
• Barriers to Effective Management of Metabolic Syndrome
• Basal Cell Carcinoma Global Clinical Trials Review, Q4, 2010
• Basen (Type 2 Diabetes) - Analysis and Forecasts to 2020
• BASF: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
• Basic Neurochemistry. Edition No. 8
• Basic Pharmaceutical Product Manufacturing in the UK
• Basic Statistics. A Primer for the Biomedical Sciences. 4th Edition
• Baxa Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Baxter Healthcare Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Baxter International Inc,(BAX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Bayer AG,(BAYRY) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Bayer CropScience LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bayer Innovation GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bayer Technology Services GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bayer's and J&J's Xarelto - A new oral anticoagulant with broad clinical application
• Bayer: Performance, Capabilities, Goals and Strategies in the Worldwide Animal Health Market
• Bayesian Approaches to Clinical Trials and Health-Care Evaluation. Statistics in Practice
• Bayesian Methods and Ethics in a Clinical Trial Design. Wiley Series in Probability and Statistics
• Bayhill Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BC Cancer Agency - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BD Biosciences - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Beactica AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Becton Dickinson & Co,(BDX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Behavioral Neurology in the Elderly
• Being Interprofessional
• Belarus Pharmaceuticals and Healthcare Report Q1 2010
• Belarus Pharmaceuticals and Healthcare Report Q1 2013
• Belarus Pharmaceuticals and Healthcare Report Q2 2009
• Belarus Pharmaceuticals and Healthcare Report Q2 2011
• Belarus Pharmaceuticals and Healthcare Report Q2 2013
• Belarus Pharmaceuticals and Healthcare Report Q3 2009
• Belarus Pharmaceuticals and Healthcare Report Q3 2010
• Belarus Pharmaceuticals and Healthcare Report Q4 2009
• Belarus Pharmaceuticals and Healthcare Report Q4 2011
• Belarus Pharmaceuticals and Healthcare Report Q4 2012
• Belarus Pharmaceuticals and Helathcare Report Q3 2012
• Belgium Drug Patent Inventor Report - 2012
• Belgium Pharmaceutical Market Analysis, 2010-2014
• Belgium Pharmaceuticals & Healthcare Report Q1 2008
• Belgium Pharmaceuticals and Healthcare Report Q1 2012
• Belgium Pharmaceuticals and Healthcare Report Q1 2013
• Belgium Pharmaceuticals and Healthcare Report Q2 2009
• Belgium Pharmaceuticals and Healthcare Report Q2 2012
• Belgium Pharmaceuticals and Healthcare Report Q2 2013
• Belgium Pharmaceuticals and Healthcare Report Q3 2011
• Belgium Pharmaceuticals and Healthcare Report Q4 2011
• Belgium Pharmaceuticals and Healthcare Report Q4 2012
• Belgium: Pharmaceuticals Industry Guide
• Bellicum Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BELLUS Health Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Benchmarking the Patient Movement Part 1 (Ten Different Countries/Regions)
• Benchmarking the Patient Movement Part 2 (Eleven Therapeutic Areas)
• Bend Research, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bendamustine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
• Bendamustine - Key patent, SPC, and data exclusivity expiry (7 country coverage)
• Benign Prostatic Hyperplasia (BPH) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
• Benign Prostatic Hyperplasia - Pipeline Review, H1 2012
• Benign Prostatic Hyperplasia - Pipeline Review, H1 2013
• Benign Prostatic Hyperplasia - Pipeline Review, H2 2011
• Benign Prostatic Hyperplasia - Pipeline Review, H2 2012
• Benign Prostatic Hyperplasia - Pipeline Review, Q1 2011
• Benign Prostatic Hyperplasia - Pipeline Review, Q4 2010
• Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms (Event Driven)
• Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2011
• Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2012
• Benign Prostatic Hyperplasia Global Clinical Trials Review, Q2, 2011
• Benign Prostatic Hyperplasia Therapy Area Pipeline Report
• Berman Center, Inc.,(BRMC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Bespak Injectables (formerly The Medical House PLC) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Best Practice for Clinical Monitoring
• Best Practices for Advertising to Life Scientists: Online and in Print
• Beta 2-agonists in Asthma Treatment. Lung Biology in Health and Disease
• Beyond Disease Management: Strategies for Improving Patient Care and Cutting Costs
• Beyond Expression Arrays: Emerging Applications for Genomic Microarray Technology
• Beyond Managed Care. How Consumers and Technology Are Changing the Future of Health Care
• Beyond the Zonules of Zinn. A Fantastic Journey Through Your Brain
• BG Medicine, Inc.,(BGMD) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• BI 10773 (Type 2 Diabetes) - Analysis and Forecasts to 2020
• BIAL - Portela & Ca., S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bicycle Therapeutics, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Big Multinational Pharma in China
• Big Pharma Company Outlook to 2016
• Big Pharma Embraces Pharmacogenomics - But Are We There Yet?
• Big Pharma M&A Analysis to 2012 - Surveying the Growth Rate Landscape
• Big Pharma Mega-Mergers 1995-2014
• Big Pharma Performance Before, During and Beyond the Global Recession
• Big Pharma's Key Lifecycle Management Strategies - Maximizing the Market Potential
• Big Pharma’s New Licensing Strategies
• BigDNA, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bile Duct Cancer Global Clinical Trials Review, Q4, 2010
• Biliary Atresia Global Clinical Trials Review, H1, 2012
• Biliary Atresia Global Clinical Trials Review, Q1, 2011
• Biliary Cirrhosis - Pipeline Review, H2 2011
• Biliary Cirrhosis - Pipeline Review, H2 2012
• Biliary Cirrhosis - Pipeline Review, Q2 2011
• Biliary Cirrhosis - Pipeline Review, Q4 2010
• Biliary Cirrhosis Global Clinical Trials Review, H2, 2011
• Biliary Cirrhosis Global Clinical Trials Review, H2, 2012
• Biliary Cirrhosis Global Clinical Trials Review, Q1, 2011
• Biliary Tract Disease Global Clinical Trials Review, H2, 2011
• Biliary Tract Disease Global Clinical Trials Review, H2, 2012
• Biliary Tract Disease Global Clinical Trials Review, Q1, 2011
• Bio Rad Laboratories Inc,(BIO) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Bio Reference Laboratories Inc,(BRLI) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Bio-Path Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bio-Rad Laboratories, Inc. - SWOT Analysis
• Bio/Pharma R&D Statistical Sourcebook 2010/2011
• Bioadhesive Drug Delivery Systems. Fundamentals, Novel Approaches, and Development. Drugs and the Pharmaceutical Sciences
• Bioassay Techniques for Drug Development
• Biobanks - 2011 Yearbook
• Biobetters - Major Players and Market Prospects
• BioCancell Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biocartis SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bioceros B.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BioChemics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biochips for Life Science Research, Diagnostics and Drug R&D
• Biochips: Genosensors, Microarrays, Labs-on-the-Chip
• BioCision, LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BioClinica, Inc.,(BIOC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Biocode Hycel S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biocrates Life Sciences AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biodegradable Polymers as Drug Delivery Systems. Drugs and the Pharmaceutical Sciences Part No. 45
• BioDelivery Sciences International Prices Private Placement of $15m
• BioDiem, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biodrug Delivery Systems. Fundamentals, Applications and Clinical Development. Drugs and the Pharmaceutical Sciences
• Bioelectromagnetic Medicine
• BioElectronics Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BioExx Specialty Proteins, Ltd. (Formerly, Bio-Extraction, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BioForce Nanosciences Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biofrontera AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biogen IDEC Inc,(BIIB) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Biogen Idec Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT and Financial Report
• Biogen-Idec's and Elan's Tysabri - Will PML and competition derail its blockbuster potential?
• Biogen-Idec's and Facet Biotech's Daclizumab: Can it compete in the increasingly crowded multiple sclerosis market?
• Biogen-Idec's and Knopp Biosciences' dexpramipexole for amyotrophic lateral sclerosis
• BioHelix Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BioImagene, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bioinformatics in Drug Discovery
• Bioinformatics Market Update (2006)
• Bioinformatics Partnering Terms & Agreements
• Bioject Medical Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bioject Medical Technologies, Inc.,(BJCT) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Biolase Inc,(BIOL) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• BIOLASE Technology, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BioLeap, LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BioLife Solutions Inc.,(BLFS) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• BioLife Solutions, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biolik JSC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biolin Scientific AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biological Membranes in Toxicology
• Biological Monitoring of Exposure to Chemicals. Metals
• Biologics Market in Brazil
• Biologics Pipelines: Who Has the Next Promising Monoclonal Antibodies?
• Biology of Emerging Viruses. SARS, Avian and Human Influenza, Metapneumovirus, Nipah, West Nile, and Ross River Virus. Annals of the New York Academy of Sciences
• Biology of Lung Cancer. Lung Biology in Health and Disease Part No. 122
• Biomagnetics Diagnostics Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biomagnetics Diagnostics Corporation,(BMGP) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• BioMarin Pharmaceutical Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT and Financial Report
• BioMarin’s GALNS - Enzyme replacement therapy for Morquio Syndrome A
• Biomarker and Diagnostic Opportunities in Clinical Research for Neurological Diseases
• Biomarker Partnering Terms & Agreements
• Biomarker Research in Parkinson's Disease
• Biomarkers - Advanced Technologies and Global Market (2009-2014)
• Biomarkers - Promising Research, Potential Applications and New Developments
• Biomarkers and Related Tests for Molecular Diagnostics and Pharma/ Biotech R&D -- Companies Products and WW Market, 2004-2009
• Biomarkers and Tests for Pharma/ Biotech R&D – Companies Products and WW Market, 2006-2011
• Biomarkers in Clinical Drug Development. Drugs and the Pharmaceutical Sciences
• Biomarkers in Clinical Pharmacology
• Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes
• Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players
• Biomarkers, Tests and Trends for Drug R&D
• Biomarkers: Applications and Trends
• Biomatrica, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biomerica Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biomerica, Inc.,(BMRA) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• BioMerieux SA,(BMXMF) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• BioMicro Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biomics Biotechnologies Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BioMimetic Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biomoda, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biomolecular Free Radical Toxicity. Causes and Prevention
• Biomonitor A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BioNano Genomics, Inc. (BioNanomatrix, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bioniche Life Sciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bioniche Pharma USA, LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bionomics Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bionovo, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biophan Technologies Inc,(BIPH) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Biopharma M&A and Deal Making: Understanding the Latest Trends to Optimize Future Strategy
• BioPharma Outsourcing Performance
• BioPharma Productivity Crisis, What BioPharma Productivity Crisis?
• Biopharma Quarter: Key Trends and Events of the First Quarter of 2009
• Biopharma Quarter: Key Trends and Events of the Fourth Quarter of 2008
• Biopharma Quarter: Key Trends and Events of the Second Quarter of 2009
• Biopharmaceutical Companies (Global)
• Biopharmaceutical Developments--An Emerging Technology Analysis (Technical Insights)
• Biopharmaceutical Expression Systems and Genetic Engineering Technology
• BioPharmaceutical Industry in China - An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
• Biopharmaceutical Manufacturing in India, China and South Korea - Regulatory Framework, Infrastructure Support and Discovery Funding Create an Environment Conducive to Growth
• Biopharmaceutical Statistical Sourcebook 2011/2012
• Biopharmaceuticals - A Global Market Overview
• Biopharmaceuticals in the US and European Markets
• Biopolymers in Drug Delivery: Recent Advances and Challenges
• BioPorto Diagnostics A/S (formerly AntibodyShop A/S) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BioRelix, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BioScrip Inc,(BIOS) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• BioScrip, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BioSeek, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biosensors International Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biosensors International Group Ltd.,(BSNRF) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• BioServe Biotechnologies, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biosign Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biosign Technologies, Inc.,(BIO) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Biosimilar Drugs in Europe: Threat or Opportunity to Innovation?
• Biosimilar Opportunities: Pipelines and Companies
• Biosimilars
• Biosimilars (2009 - 2014)
• Biosimilars - Global Strategic Business Report
• Biosimilars Advisory Service: Physician Perspectives on Biosimilar G-CSFs and MAbs in Oncology
• Biosimilars Advisory Service: Physician Perspectives on Erythropoietin Stimulating Agents, Insulin, and Human Growth Hormone
• Biosimilars and Biobetters: Positioning for a New Market
• Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment
• Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production
• Biosimilars Regulatory Update: An Evolving Landscape
• Biosimilars Update
• Biosimilars, Biogenerics and Follow-On Biologics
• Biosimilars: A Physician's Perspective
• Biosimilars: Current Situation & Future Prospects, Worldwide
• Biostatistical Methods. The Assessment of Relative Risks. 2nd Edition. Wiley Series in Probability and Statistics
• Biosyntech, Inc.,(BSYI) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• BioSystems International - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biotage AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biotec Pharmacon ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biotech and Pharma Stock List
• Biotech Financing in the Credit Crisis: Strategies for a radically altered landscape
• Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
• Biotech Strategy 2012 - Licensing, Collaboration, and M&A Trends
• Biotechgate Company Database
• Biotechnological Innovations in the Pharmaceutical Industry in Poland 2009
• Biotechnological Innovations in the Pharmaceutical Industry in Poland 2009
• Biotechnology (UK)
• Biotechnology and Pharmaceuticals Report
• Biotechnology and Pharmaceuticals Report 2011
• Biotechnology in Personal Care. Cosmetic Science and Technology Part No. 29
• Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions
• Biotechnology of Antibiotics, Second Edition,. Drugs and the Pharmaceutical Sciences Part No. 82
• Biotecnol SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BIOTECON Diagnostics GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BioTek Instruments, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Biotherapeutic Approaches to Asthma. Lung Biology in Health and Disease
• Biotransformations in Pharmaceutical Chemistry: Current Reality and Future Possibilities
• BioVectra, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bipolar Depression - Pipeline Review, Q4 2010
• Bipolar Depression Global Clinical Trials Review, Q4, 2010
• Bipolar Disorder (Event Driven)
• Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2012
• Bipolar Disorder (Manic Depression) – Pipeline Review, H1 2013
• Bipolar Disorder - Global Strategic Business Report
• Bipolar Disorder Partnering 2007-2013
• Bipolar Disorder Therapy Area Pipeline Report
• Bipolar Disorder- Drug Pipeline Analysis and Market Forecasts to 2015
• Bipolar Disorders. Basic Mechanisms and Therapeutic Implications. Edition No. 2. Medical Psychiatry Series
• Bisphosphonates and Osteonecrosis of the Jaw. Annals of the New York Academy of Sciences
• Bisphosphonates and Other Bone-Targeting Compounds in the Treatment of Cancer
• Bivalirudin - Comprehensive patent search
• Bivalirudin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
• Bivalirudin - Key patent, SPC, and data exclusivity expiry (7 country coverage)
• Bladder Cancer - Pipeline Review, H2 2012
• Bladder Cancer - Pipeline Review, Q4 2010
• Bladder Cancer Global Clinical Trials Review, Q4, 2010
• Bladder Cancer Partnering 2007-2013
• Bladder Cancer Therapy Area Pipeline Report
• Bleeding And Clotting Disorders - Pipeline Review, H2 2012
• Blepharitis - Pipeline Review, H1 2012
• Blepharitis - Pipeline Review, H2 2011
• Blepharitis - Pipeline Review, H2 2012
• Blepharitis - Pipeline Review, Q2 2011
• Blepharitis Global Clinical Trials Review, H2, 2011
• Blepharitis Global Clinical Trials Review, H2, 2012
• Blepharitis Global Clinical Trials Review, Q1, 2011
• Blockbuster Drugs: A 2005-2014 Forecast
• Blockbuster Patent Expirations and the Future of the Generics Market
• Blockbusters Are Alive and Well: Why Their Numbers Continue to Rise
• Blockbusters going Off-patent - Opportunities for Generic Manufacturers in Europe
• Blood and Lymphatic System Anemia
• Blood and Lymphatic System Hemorrhage
• Blood Coagulation - Pipeline Review, H2 2012
• Blood Disorders Therapeutics Market to 2017 - Patent Expiries of Lovenox, Plavix, Procrit/Epogen, Aranesp and Neulasta Will Slow Down Growth
• Blood Substitute Partnering 2007-2013
• Blood Transfusion Therapy: A Physician’s Handbook, 10th Edition
• Blood-Brain Barrier
• Blue Cross and Blue Shield of Massachusetts, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT and Financial Report
• Bluegate Corporation,(BGAT) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Board Work. Governing Health Care Organizations
• Boehringer Ingelheim Vetmedica, Inc. (Formerly Boehringer Ingelheim Animal Health, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Boiron SA: Pharmaceuticals and Healthcare Company Profile, SWOT and Financial Report
• Bolder BioTechnology, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bonamour Inc,(BONI) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Bone Cancer Global Clinical Trials Review, Q4, 2010
• Bone Disorders – Pipeline Review, H1 2013
• Bone Fracture Partnering 2007-2013
• Bone Marrow Transplantation - Pipeline Review, H2 2012
• Bone Marrow Transplantation – Pipeline Review, H1 2013
• Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar
• Bone Metastases Therapy Area Pipeline Report
• Bone Metastasis - Pipeline Review, H2 2012
• Bone Metastasis Global Clinical Trials Review, Q4, 2010
• Booming Generics Drug Market in India
• Booming Pharma Sector in India
• Borderlines Between Medicines and Food (Seminar, London)
• Bordetella Pertussis Infections - Pipeline Review, H2 2012
• Boston BioCom LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Boston Scientific Corp,(BSX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Boston Therapeutics Inc,(BTHE) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Bostwick Laboratories, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Botswana Pharmaceuticals and Healthcare Report Q1 2013
• Botswana Pharmaceuticals and Healthcare Report Q2 2012
• Botswana Pharmaceuticals and Healthcare Report Q3
• Botswana Pharmaceuticals and Healthcare Report Q3 2013
• Bovie Medical Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bovie Medical Corporation,(BVX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages
• Bracco Imaging SpA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Brain and Cardiac Surgery. Causes of Neurological Complications and Their Prevention
• Brain Arousal and Information Theory. Neural and Genetic Mechanisms
• Brain Cancer - Pipeline Review, H2 2012
• Brain Cancer Global Clinical Trials Review, Q4, 2010
• Brain Cancer Partnering 2007-2013
• Brain Embolism. Neurological Disease and Therapy Part No. 81
• Brain Hemorrhage - Pipeline Review, Q4 2010
• Brain Ischemia - Pipeline Review, H1 2012
• Brain Metastasis - Pipeline Review, H2 2012
• Brain Metastasis Global Clinical Trials Review, Q4, 2010
• Brain Tumor – Pipeline Review, H1 2013
• Brain Tumor Therapy Area Pipeline Report
• Brain Tumors. Practical Guide to Diagnosis and Treatment. Neurological Disease and Therapy
• BrainCells, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BrainScope Company, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Brand Name Pharmaceutical Manufacturing in the US
• Brand Planning for the Pharmaceutical Industry
• Branded Prescription Pharmaceutical Sales Outlook to 2016
• Branded vs Generic Drugs in Latin America
• Branded vs Generic Drugs in Russia and CEE – Expert Insights
• Brazil - Pharmaceutical Industry Overview
• Brazil Diabetes Market Report & Forecast 2011-2016
• Brazil Generics Market Forecast to 2012
• Brazil Pharmaceutical Market Analysis, 2010-2014
• Brazil Pharmaceutical Market Overview - Expanding healthcare access drives double-digit sales growth
• Brazil Pharmaceuticals and Healthcare Report Q1 2008
• Brazil Pharmaceuticals and Healthcare Report Q1 2009
• Brazil Pharmaceuticals and Healthcare Report Q1 2010
• Brazil Pharmaceuticals and Healthcare Report Q1 2012
• Brazil Pharmaceuticals and Healthcare Report Q1 2013
• Brazil Pharmaceuticals and Healthcare Report Q2 2008
• Brazil Pharmaceuticals and Healthcare Report Q2 2009
• Brazil Pharmaceuticals and Healthcare Report Q2 2010
• Brazil Pharmaceuticals and Healthcare Report Q2 2011
• Brazil Pharmaceuticals and Healthcare Report Q2 2013
• Brazil Pharmaceuticals and Healthcare Report Q3 2007
• Brazil Pharmaceuticals and Healthcare Report Q3 2008
• Brazil Pharmaceuticals and Healthcare Report Q4 2009
• Brazil Pharmaceuticals and Healthcare Report Q4 2010
• Brazil Pharmaceuticals and Healthcare Report Q4 2012
• Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders
• Breakthrough Performance. Accelerating the Transformation of Health Care Organizations
• Breast Cancer Global Clinical Trials Review, Q4, 2010
• Breast Cancer Partnering 2007-2013
• Breast Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017
• Breast Cancer Therapy Area Pipeline Report
• Breast Cancer Vaccines and Therapeutic Antibodies: Pipeline - 2011
• Breast MRI in Practice
• Breckenridge Pharmaceutical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• BRIC by BRIC, Building Russian Pharma
• BRIC Diabetes Drugs Market (2010-2015)
• Bridge Laboratories - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
• Bridging the Pharmaceutical Earnings gap: Key Strategies in the race for growth
• Brief Report: GM-CSF Antibodies
• Brief Report: Interleukin-12 (IL-12) and IL-23 Antagonists
• Brief Report: Interleukin-13 (IL-13) Antibodies
• Brief Report: Interleukin-17 (IL-17R) and IL-17 Receptor Antagonists
• Brief Report: Syk Kinase Inhibitors
• Brigham and Women's Hospital - Developmental Therapeutics Review - Q1 2011